A Case of Pharmacokinetics of Cisplatin in Concurrent Chemoradiation for Hemodialysis Patient with Advanced Head and Neck Cancer |
Jeon, Youn-Joo
(Departments of Internal Medicine, St. Vincent's Hospital)
Shim, Byoung-Yong (Departments of Internal Medicine, St. Vincent's Hospital) Kim, Hyung-Wook (Departments of Internal Medicine, St. Vincent's Hospital) Lee, Sang-Hun (Departments of Internal Medicine, St. Vincent's Hospital) Lee, Ho-Sang (Departments of Internal Medicine, St. Vincent's Hospital) Park, Cheol-Whee (Departments of Internal Medicine, St. Vincent's Hospital) Kim, Su-Zy (Departments of Radiation Oncology, St. Vincent's Hospital) Kuh, Hyo-Jeong (Catholic Research Institutes of Medical Science) Kim, Hoon-Kyo (Departments of Internal Medicine, St. Vincent's Hospital) |
1 | Watanabe R, Takiguchi Y, Moriya T, et al: Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer. Br J Cancer. 2003;88:25-30 DOI ScienceOn |
2 | Bikfalvi A, Seiler KU, Schmitz N, Loffler H: Cytotoxic chemotherapy with cisplatin in an anuric patient undergoing hemodialysis. Tumor Diagn Ther. 1986;7:42-43 |
3 | Umeki S, Wakunami M, Kawane H, Soegima R: Squamous cell carcinoma of the lung detected during maintenance haemodialysis which reduced in size after combined CDDP chemotherapy. Jpn J Thorac Dis. 1990;28:1225-1229 |
4 | Bennet WM, Aronoff GR, Morrison G, et al: Drug prescribing in renal failure: dosing guideline for adults. Am J Kidney Dis. 1983;3:155-193 DOI |
5 | Kurisu A, Hata T, Owada A: Full-dose chemotherapy for esophageal cancer patient under hemodialysis. Nephron. 2002;92:960 |
6 | LeRoy AF, Wheling ML, sponseller HL, et al: Analysis of platinum in biological materials by flameless atomic absorbtion spectrophotometry. Biochem Med. 1977;18:184-191 DOI ScienceOn |
7 | Gorodetsky R, Vexler A, Bar-Khaim Y, Biran H: Plasma Platinum Elimination in a Hemodialysis Patient Treated with Cisplatin. Ther Drug Monit. 1995;17:203-206 DOI ScienceOn |
8 | Sauer H, Fuger K, Blumenstein M: Modulation of cytotoxicity of cytostatic drugs by hemodialysis in vitro and in vivo. Cancer Treat Rev. 1990;72:446-454 |
9 | Ono S, Miyazaki T, Nishikawa K, Watanabe K, Hisanaga S: Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial haemodialysis(in Japanese, English abstract). Jpn J Cancer Chemother. 1992;19:115-118 |
10 | Maisonneuve P, Agodoa L, Gellert R, et al: Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93-99 DOI ScienceOn |
11 | Goutyette A, Lemoine R, Adhemar J, et al: Kinetics of cisplatin in an anuric patient undergoing hemofiltration. Dialysis Cancer Treat Rep. 1981;65:665-668 |
12 | Palestini M, Lucandri G, Sterpetti A, Izzo L, Orefici F, Cavallaro A: Cancer surveillance in patients receiving long-term hemodialysis. Anticancer Res. 2002;22:1305-1310 |
13 | Tanabe N, Goto M, Morita H, et al: Pharmacokinetics of cisdiammine- dichlor-platin in a hemodialysis patient. Cancer Invest. 1991;9:629-635 DOI ScienceOn |